After praziquantel treatment for schistosomiasis, parasitological cure rates of 60%–90% are usual. Does this response to treatment correlate with the improvement in liver and bladder changes seen on ultrasound in children? This study shows that ultrasound is an effective way to evaluate liver and bladder changes caused by schistosomiasis infection in children and to assess treatment effects after mass treatment programmes.
GreyseelsBMbayeADe VlasSJ. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop Med Int Health2001; 6: 864–873.
2.
UtzingerJN’GoranEKN’DriA. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Trop Med Int Health2000; 5: 771–778.
3.
CotaGFPinto-SilvaRAAntunesCMF. Ultrasound and clinical investigation of hepatosplenic schistosomiasis: evaluation of splenomegaly and liver fibrosis four years after mass chemotherapy with Oxamniquine. Am J Trop Med Hyg2006; 74: 103–107.
4.
BurchardGDGuisse-SowFDiopM. Schistosoma mansoni infection in a recently exposed community in Senegal: lack of correlation between liver morphology in ultrasound and connective tissue metabolites in serum. Trop Med Int Health1998; 3: 234–241.
5.
Richter J, Hatz C, Campagne G, et al., eds. Ultrasound in Schistosomiasis: a Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis-related Morbidity. Geneva: World Health Organization. http://whqlibdoc.who.int/hq/2000/TDR_STR_SCH_00.1.pdf (accessed 20 August 2012).
6.
KingCHMagakPSalamEA. Measuring morbidity in Schistosoma mansoni: relationship between image pattern, portal vein diameter and portal branch thickness in large-scale surveys using new WHO coding guidelines for ultrasound in schistosomiasis. Trop Med Int Health2003; 8: 109–117.
7.
BerheNGeitungJTMedhinG. Large scale evaluation of WHO’s ultrasonographic staging system of schistosomal periportal fibrosis in Ethiopia. Trop Med Int Health2006; 11: 1286–1294.
8.
BerheNMyrvangBGundersenSG. Reversibility of schistosomal periportal thickening/fibrosis after praziquantel therapy: a twenty-six month follow-up study in Ethiopia. Am J Trop Med Hyg2008; 78: 228–234.
9.
Ruiz-GuevaraRde NoyaBAValeroSK. Clinical and ultrasound findings before and after praziquantel treatment among Venezuelan schistosomiasis patients. Rev Soc Brasileira Med Trop2007; 40: 505–511.
10.
BlackCLSteinauerMLMwinziPNM. Impact of intense, longitudinal retreatment with praziquantel on cure rates of Schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya. Trop Med Int Health2009; 14: 450–457.
